Q61 refers to Cystic kidney disease, a category covering congenital abnormalities affecting the kidneys, renal pelvis, ureters, or urinary tract system detected prenatally or after birth.
Diagnosis often involves prenatal ultrasound screening, postnatal renal ultrasounds, voiding cystourethrograms (VCUG), MRI scans, and sometimes genetic testing to identify congenital anomalies of the kidney and urinary tract.
ICD10 code Q61 is critical for documenting congenital kidney or urinary malformations in medical records, insurance coding, surgical referrals, and long-term renal management planning.
Q1: What is ICD10 code Q61?
A: It documents Cystic kidney disease, covering congenital abnormalities of the kidneys, ureters, or urinary system.
Q2: Can kidney agenesis (Q60) be fatal?
A: Bilateral renal agenesis (no kidneys) is typically fatal without intervention; unilateral cases may live normal lives.
Q3: How is cystic kidney disease managed?
A: It depends on severity but may involve monitoring, blood pressure control, and sometimes surgical interventions.
Q4: Are obstructive urinary defects always symptomatic?
A: Some cause early symptoms (e.g., hydronephrosis), while others are discovered incidentally.
Q5: Can these defects be corrected surgically?
A: Yes, many obstructive and anatomical issues can be surgically corrected to preserve kidney function.
ICD10 code Q61 ensures accurate documentation of Cystic kidney disease, aiding early diagnosis, appropriate intervention, and better outcomes for individuals with congenital kidney and urinary tract malformations.
Get started for $0 – no credit card needed. You'll get up to 20 sessions free.
Start Free Trial